Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Price to Sales Ratio 2010-2024 | MKKGY

Historical PS ratio values for Merck (MKKGY) over the last 10 years. The current P/S ratio for Merck as of November 22, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Merck P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
0.00 nan
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $19.083B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.838B 30.72
Takeda Pharmaceutical (TAK) Japan $42.573B 8.86
Sandoz Group AG (SDZNY) Switzerland $19.533B 0.00
Astellas Pharma (ALPMY) Japan $18.260B 16.82
United Therapeutics (UTHR) United States $16.648B 16.38
Summit Therapeutics (SMMT) United States $14.012B 0.00
Neurocrine Biosciences (NBIX) United States $12.722B 33.69
Shionogi (SGIOY) Japan $12.010B 11.51
Catalent (CTLT) United States $11.069B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.658B 7.49
Madrigal Pharmaceuticals (MDGL) United States $7.578B 0.00
Orion OYJ (ORINY) Finland $6.653B 18.71
Corcept Therapeutics (CORT) United States $6.029B 45.67
Ionis Pharmaceuticals (IONS) United States $5.370B 0.00
Crinetics Pharmaceuticals (CRNX) United States $5.199B 0.00
PTC Therapeutics (PTCT) United States $3.334B 0.00
Dyne Therapeutics (DYN) United States $3.021B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.600B 15.54
Catalyst Pharmaceuticals (CPRX) United States $2.562B 11.61
Soleno Therapeutics (SLNO) United States $2.491B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.305B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.931B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.866B 0.00
Xencor (XNCR) United States $1.750B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.634B 0.00
Evotec AG (EVO) Germany $1.591B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.574B 0.00
Harrow (HROW) United States $1.528B 0.00
Indivior (INDV) United States $1.500B 6.11
Guardian Pharmacy Services (GRDN) United States $1.461B 0.00
Ocular Therapeutix (OCUL) United States $1.388B 0.00
ARS Pharmaceuticals (SPRY) United States $1.361B 0.00
Cassava Sciences (SAVA) United States $1.274B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.269B 0.00
Ardelyx (ARDX) United States $1.258B 0.00
Enliven Therapeutics (ELVN) United States $1.199B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.124B 0.00
Collegium Pharmaceutical (COLL) United States $0.966B 5.27
Bioventus (BVS) United States $0.950B 30.03
Cronos Group (CRON) Canada $0.795B 0.00
Relay Therapeutics (RLAY) United States $0.795B 0.00
USANA Health Sciences (USNA) United States $0.760B 14.10
Oruka Therapeutics (ORKA) United States $0.726B 0.00
Elite Pharmaceuticals (ELTP) United States $0.659B 0.00
Altimmune (ALT) United States $0.617B 0.00
Tourmaline Bio (TRML) United States $0.590B 0.00
Savara (SVRA) United States $0.577B 0.00
OmniAb (OABI) United States $0.554B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.551B 0.00
Organogenesis (ORGO) United States $0.537B 0.00
Zevra Therapeutics (ZVRA) United States $0.512B 0.00
Esperion Therapeutics (ESPR) United States $0.497B 0.00
ProKidney (PROK) United States $0.493B 0.00
Korro Bio (KRRO) United States $0.490B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.466B 0.00
Siga Technologies (SIGA) United States $0.463B 5.40
Xeris Biopharma Holdings (XERS) United States $0.461B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.459B 186.00
KalVista Pharmaceuticals (KALV) United States $0.439B 0.00
Aquestive Therapeutics (AQST) United States $0.416B 0.00
Verve Therapeutics (VERV) United States $0.411B 0.00
Akebia Therapeutics (AKBA) United States $0.410B 0.00
Larimar Therapeutics (LRMR) United States $0.393B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.361B 0.00
4D Molecular Therapeutics (FDMT) United States $0.360B 0.00
Avita Medical (RCEL) United States $0.350B 0.00
Sage Therapeutics (SAGE) United States $0.316B 0.00
Nature's Sunshine Products (NATR) United States $0.296B 17.58
Aldeyra Therapeutics (ALDX) United States $0.289B 0.00
Aclaris Therapeutics (ACRS) United States $0.271B 0.00
Lyell Immunopharma (LYEL) United States $0.265B 0.00
Lexeo Therapeutics (LXEO) United States $0.214B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.213B 0.00
Silence Therapeutics (SLN) United Kingdom $0.210B 0.00
Acrivon Therapeutics (ACRV) United States $0.204B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.198B 0.00
Nektar Therapeutics (NKTR) United States $0.194B 0.00
Profound Medical (PROF) Canada $0.186B 0.00
Nanobiotix S.A (NBTX) France $0.179B 0.00
MediWound (MDWD) Israel $0.178B 0.00
Galectin Therapeutics (GALT) United States $0.174B 0.00
Heron Therapeutics (HRTX) United States $0.163B 0.00
Inhibikase Therapeutics (IKT) United States $0.155B 0.00
Achieve Life Sciences (ACHV) Canada $0.148B 0.00
CytoDyn (CYDY) United States $0.140B 0.00
VAXART, INC (VXRT) United States $0.136B 0.00
Cardiol Therapeutics (CRDL) Canada $0.132B 0.00
Telomir Pharmaceuticals (TELO) United States $0.126B 0.00
Pyxis Oncology (PYXS) United States $0.113B 0.00
Journey Medical (DERM) United States $0.112B 0.00
Karyopharm Therapeutics (KPTI) United States $0.106B 0.00
Avalo Therapeutics (AVTX) United States $0.105B 0.00
Context Therapeutics (CNTX) United States $0.104B 0.00
Century Therapeutics (IPSC) United States $0.103B 0.00
Innate Pharma SA (IPHYF) France $0.103B 0.00
Fractyl Health (GUTS) United States $0.101B 0.00
Regulus Therapeutics (RGLS) United States $0.096B 0.00
Inotiv (NOTV) United States $0.093B 0.00
Assertio Holdings (ASRT) United States $0.090B 23.52
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Relmada Therapeutics (RLMD) United States $0.084B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
ESSA Pharma (EPIX) Canada $0.081B 0.00
Vivani Medical (VANI) United States $0.079B 0.00
CASI Pharmaceuticals (CASI) China $0.079B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 0.00
ElectroCore (ECOR) United States $0.073B 0.00
OptiNose (OPTN) United States $0.072B 0.00
Metagenomi (MGX) United States $0.071B 0.00
Scienture Holdings (SCNX) United States $0.065B 0.00
AlloVir (ALVR) United States $0.064B 0.00
Champions Oncology (CSBR) United States $0.062B 0.00
Mural Oncology (MURA) Ireland $0.057B 0.00
Unicycive Therapeutics (UNCY) United States $0.055B 0.00
BioVie (BIVI) United States $0.054B 0.00
Nutriband (NTRB) United States $0.053B 0.00
Prelude Therapeutics (PRLD) United States $0.052B 0.00
Iterum Therapeutics (ITRM) Ireland $0.050B 0.00
Protara Therapeutics (TARA) United States $0.049B 0.00
Rafael Holdings (RFL) United States $0.047B 0.00
Gain Therapeutics (GANX) United States $0.046B 0.00
SCYNEXIS (SCYX) United States $0.046B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.045B 0.00
VYNE Therapeutics (VYNE) United States $0.045B 0.00
FibroGen (FGEN) United States $0.040B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.036B 0.00
Incannex Healthcare (IXHL) Australia $0.035B 0.00
Carisma Therapeutics (CARM) United States $0.034B 0.00
CERo Therapeutics Holdings (CERO) United States $0.033B 0.00
DURECT (DRRX) United States $0.031B 0.00
Surrozen (SRZN) United States $0.030B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.028B 0.00
Lipocine (LPCN) United States $0.028B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
BioLineRx (BLRX) Israel $0.022B 0.00
GlycoMimetics (GLYC) United States $0.020B 0.00
Enlivex Therapeutics (ENLV) Israel $0.020B 0.00
MEI Pharma (MEIP) United States $0.019B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Mannatech (MTEX) United States $0.016B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
NRx Pharmaceuticals (NRXP) United States $0.015B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.015B 0.00
Traws Pharma (TRAW) United States $0.014B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.013B 0.00
Nuvilex (PMCB) United States $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Jaguar Animal Health (JAGX) United States $0.012B 0.00
Talphera (TLPH) United States $0.012B 0.00
Conduit Pharmaceuticals (CDT) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Dominari Holdings (DOMH) United States $0.010B 0.00
Redhill Biopharma (RDHL) Israel $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Klotho Neurosciences (KLTO) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Biomerica (BMRA) United States $0.005B 0.00
Aditxt (ADTX) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Aptorum Group (APM) United Kingdom $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.004B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Oncternal Therapeutics (ONCT) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Molecular Templates (MTEM) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 1.77
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 38.53